Global and China Cystic Fibrosis Drugs Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The symptoms of cystic fibrosis depend on the organ of the body it affects. For example, if the disease is related to the lungs, the person will experience symptoms such as sputum production and persistent coughing, wheezing, nasal congestion, and recurrent lung infections. Cystic fibrosis has no known cure as of now. There are drugs to treat cystic fibrosis that can help relieve symptoms.

    Over the past few years, the market has grown steadily and has been sustained by the rising prevalence of cystic fibrosis, advances in screening and treatment technology, and rising smoking rates. The Global Cystic Fibrosis Drugs Market will grow at a CAGR of more than 10% during the forecast period 2020-2026.

    Initiatives from governments and other organizations, promising cystic fibrosis treatment pipelines, and market expansion opportunities in emerging countries are providing room for growth in the cystic fibrosis drug market. However, the complex drug development process and expensive treatment options will limit the cystic fibrosis drug market growth.

    This report elaborates on the current development of the Cystic Fibrosis Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Venus Remedies

    • Novartis

    • PTC Therapeutics

    • Anthera Pharmaceuticals

    • Gilead Sciences

    • Chiesi Farmaceutici

    • Johnson & Johnson

    • Pharmaxis

    • Novo Nordisk

    • Merck Sharp & Dohme

    • Boehringer Ingelheim

    • Neovii Biotech

    • Genzyme

    • Arcturus Therapeutics

    • Actavis

    • Insmed

    • Vertex Pharmaceuticals

    • Proteostasis Therapeutics

    • PharmaSwiss

    • United Medical

    • Corbus Pharmaceuticals

    • Abbott

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Oral

    • Injection

    Application:

    • Hospitals

    • Clinics

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Cystic Fibrosis Drugs Industry Overview

      • 1.1.1 Cystic Fibrosis Drugs Market Scope and Market Segments

      • 1.1.2 Cystic Fibrosis Drugs Industry Characteristics

      • 1.1.3 Global and China Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Cystic Fibrosis Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Cystic Fibrosis Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Oral

      • 1.2.2 Injection

    • 1.3 Global Cystic Fibrosis Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Cystic Fibrosis Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Cystic Fibrosis Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Cystic Fibrosis Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Cystic Fibrosis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Cystic Fibrosis Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Cystic Fibrosis Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Cystic Fibrosis Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Cystic Fibrosis Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Cystic Fibrosis Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Cystic Fibrosis Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Cystic Fibrosis Drugs Industry PEST Analysis

    • 2.3 Cystic Fibrosis Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Cystic Fibrosis Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Cystic Fibrosis Drugs Industry

    Chapter 3 Global and China Cystic Fibrosis Drugs Market, by Manufacturer

    • 3.1 Global and China Cystic Fibrosis Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Cystic Fibrosis Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Cystic Fibrosis Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Cystic Fibrosis Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Cystic Fibrosis Drugs Market Top 3 Players

    Chapter 4 Global and China Cystic Fibrosis Drugs Market, by Type (2017-2028)

    • 4.1 Cystic Fibrosis Drugs Market Trend, by Type

    • 4.2 Global Cystic Fibrosis Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Cystic Fibrosis Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Cystic Fibrosis Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Cystic Fibrosis Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Cystic Fibrosis Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Cystic Fibrosis Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Cystic Fibrosis Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Cystic Fibrosis Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Cystic Fibrosis Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Cystic Fibrosis Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Cystic Fibrosis Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Cystic Fibrosis Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Cystic Fibrosis Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Cystic Fibrosis Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Cystic Fibrosis Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Cystic Fibrosis Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Cystic Fibrosis Drugs Market Analysis

    • 7.1 North America Cystic Fibrosis Drugs Market, by Type

    • 7.2 North America Cystic Fibrosis Drugs Market, by Application

    • 7.3 North America Cystic Fibrosis Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Cystic Fibrosis Drugs Market Analysis

    • 8.1 Europe Cystic Fibrosis Drugs Market, by Type

    • 8.2 Europe Cystic Fibrosis Drugs Market, by Application

    • 8.3 Europe Cystic Fibrosis Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Cystic Fibrosis Drugs Market Analysis

    • 9.1 APAC Cystic Fibrosis Drugs Market, by Type

    • 9.2 APAC Cystic Fibrosis Drugs Market, by Application

    • 9.3 APAC Cystic Fibrosis Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Cystic Fibrosis Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Cystic Fibrosis Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Cystic Fibrosis Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Cystic Fibrosis Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Cystic Fibrosis Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Cystic Fibrosis Drugs Company Profiles

      • 11.1 Venus Remedies

        • 11.1.1 Venus Remedies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Venus Remedies Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.1.3 Venus Remedies Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Novartis

        • 11.2.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Novartis Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.2.3 Novartis Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 PTC Therapeutics

        • 11.3.1 PTC Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 PTC Therapeutics Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.3.3 PTC Therapeutics Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Anthera Pharmaceuticals

        • 11.4.1 Anthera Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Anthera Pharmaceuticals Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.4.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Gilead Sciences

        • 11.5.1 Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Gilead Sciences Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.5.3 Gilead Sciences Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Chiesi Farmaceutici

        • 11.6.1 Chiesi Farmaceutici Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Chiesi Farmaceutici Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.6.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Johnson & Johnson

        • 11.7.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Johnson & Johnson Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.7.3 Johnson & Johnson Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Pharmaxis

        • 11.8.1 Pharmaxis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Pharmaxis Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.8.3 Pharmaxis Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Novo Nordisk

        • 11.9.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Novo Nordisk Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.9.3 Novo Nordisk Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Merck Sharp & Dohme

        • 11.10.1 Merck Sharp & Dohme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Merck Sharp & Dohme Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.10.3 Merck Sharp & Dohme Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Boehringer Ingelheim

        • 11.11.1 Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Boehringer Ingelheim Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.11.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Neovii Biotech

        • 11.12.1 Neovii Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Neovii Biotech Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.12.3 Neovii Biotech Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Genzyme

        • 11.13.1 Genzyme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Genzyme Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.13.3 Genzyme Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Arcturus Therapeutics

        • 11.14.1 Arcturus Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Arcturus Therapeutics Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.14.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Actavis

        • 11.15.1 Actavis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Actavis Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.15.3 Actavis Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Insmed

        • 11.16.1 Insmed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Insmed Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.16.3 Insmed Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 Vertex Pharmaceuticals

        • 11.17.1 Vertex Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 Vertex Pharmaceuticals Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.17.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Proteostasis Therapeutics

        • 11.18.1 Proteostasis Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Proteostasis Therapeutics Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.18.3 Proteostasis Therapeutics Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 PharmaSwiss

        • 11.19.1 PharmaSwiss Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 PharmaSwiss Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.19.3 PharmaSwiss Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 United Medical

        • 11.20.1 United Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 United Medical Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.20.3 United Medical Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Corbus Pharmaceuticals

        • 11.21.1 Corbus Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Corbus Pharmaceuticals Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.21.3 Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Abbott

        • 11.22.1 Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Abbott Cystic Fibrosis Drugs Product Profiles, Application and Specification

        • 11.22.3 Abbott Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Cystic Fibrosis Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Cystic Fibrosis Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Cystic Fibrosis Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Cystic Fibrosis Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Market Size and Growth Rate of Oral (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Market Size and Growth Rate of Injection (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Cystic Fibrosis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Cystic Fibrosis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Cystic Fibrosis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Cystic Fibrosis Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Cystic Fibrosis Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Cystic Fibrosis Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Cystic Fibrosis Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Cystic Fibrosis Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Cystic Fibrosis Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Cystic Fibrosis Drugs Market Share, by Manufacturer in 2022

    • Table Global Cystic Fibrosis Drugs Sales Volume, by Type (2017-2028)

    • Table Global Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Cystic Fibrosis Drugs Sales Value, by Type (2017-2028)

    • Table Global Cystic Fibrosis Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Price Trend, by Type (2017-2028)

    • Table China Cystic Fibrosis Drugs Sales Volume, by Type (2017-2028)

    • Table China Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Cystic Fibrosis Drugs Sales Value, by Type (2017-2028)

    • Table China Cystic Fibrosis Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Cystic Fibrosis Drugs Price Trend, by Type (2017-2028)

    • Table Global Cystic Fibrosis Drugs Sales Volume, by Application (2017-2028)

    • Table Global Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Cystic Fibrosis Drugs Sales Value, by Application (2017-2028)

    • Table Global Cystic Fibrosis Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Cystic Fibrosis Drugs Sales Value Share, by Application (2017-2028)

    • Table China Cystic Fibrosis Drugs Sales Volume, by Application (2017-2028)

    • Table China Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Cystic Fibrosis Drugs Sales Value, by Application (2017-2028)

    • Table China Cystic Fibrosis Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Cystic Fibrosis Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Cystic Fibrosis Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Cystic Fibrosis Drugs Sales Volume, by Type (2017-2028)

    • Table North America Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Cystic Fibrosis Drugs Sales Volume, by Application (2017-2028)

    • Table North America Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Cystic Fibrosis Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Cystic Fibrosis Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Cystic Fibrosis Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Cystic Fibrosis Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Cystic Fibrosis Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Cystic Fibrosis Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Cystic Fibrosis Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Cystic Fibrosis Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Cystic Fibrosis Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Cystic Fibrosis Drugs Sales Value and Growth Rate (2017-2028)

    • Table Venus Remedies Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Venus Remedies Product Profiles, Application and Specification

    • Table Venus Remedies Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PTC Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PTC Therapeutics Product Profiles, Application and Specification

    • Table PTC Therapeutics Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Anthera Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Anthera Pharmaceuticals Product Profiles, Application and Specification

    • Table Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gilead Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gilead Sciences Product Profiles, Application and Specification

    • Table Gilead Sciences Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Chiesi Farmaceutici Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Chiesi Farmaceutici Product Profiles, Application and Specification

    • Table Chiesi Farmaceutici Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pharmaxis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pharmaxis Product Profiles, Application and Specification

    • Table Pharmaxis Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk Product Profiles, Application and Specification

    • Table Novo Nordisk Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Sharp & Dohme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Sharp & Dohme Product Profiles, Application and Specification

    • Table Merck Sharp & Dohme Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim Product Profiles, Application and Specification

    • Table Boehringer Ingelheim Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Neovii Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Neovii Biotech Product Profiles, Application and Specification

    • Table Neovii Biotech Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Genzyme Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Genzyme Product Profiles, Application and Specification

    • Table Genzyme Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arcturus Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arcturus Therapeutics Product Profiles, Application and Specification

    • Table Arcturus Therapeutics Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Actavis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Actavis Product Profiles, Application and Specification

    • Table Actavis Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Insmed Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Insmed Product Profiles, Application and Specification

    • Table Insmed Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Vertex Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Vertex Pharmaceuticals Product Profiles, Application and Specification

    • Table Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Proteostasis Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Proteostasis Therapeutics Product Profiles, Application and Specification

    • Table Proteostasis Therapeutics Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table PharmaSwiss Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table PharmaSwiss Product Profiles, Application and Specification

    • Table PharmaSwiss Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table United Medical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table United Medical Product Profiles, Application and Specification

    • Table United Medical Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Corbus Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Corbus Pharmaceuticals Product Profiles, Application and Specification

    • Table Corbus Pharmaceuticals Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Abbott Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Product Profiles, Application and Specification

    • Table Abbott Cystic Fibrosis Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.